First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy

被引:25
作者
Haim, M. S. [1 ,2 ]
Di Gregorio, S. [1 ,2 ]
Galanternik, L. [3 ]
Lubovich, S. [4 ]
Vazquez, M. [3 ]
Bharat, A. [5 ]
Zaheer, R. [5 ]
Golding, G. R. [5 ,6 ]
Graham, M. [5 ,6 ]
Van Domselaar, G. [5 ,6 ]
Cardona, S. T. [6 ,7 ]
Mollerach, M. [1 ,2 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina
[3] Hosp Ninos Dr Ricardo Gutierrez, Lab Cent, Microbiol, Buenos Aires, DF, Argentina
[4] Hosp Ninos Dr Ricardo Gutierrez, Ctr Resp, Buenos Aires, DF, Argentina
[5] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada
[6] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada
[7] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada
关键词
SUSCEPTIBILITY; MUTANTS;
D O I
10.1016/j.ijantimicag.2017.10.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:739 / 741
页数:3
相关论文
共 5 条
[1]   The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility [J].
Beabout, Kathryn ;
Hammerstrom, Troy G. ;
Perez, Anisha Maria ;
Magalhaes, Barbara Freitas ;
Prater, Amy G. ;
Clements, Thomas P. ;
Arias, Cesar A. ;
Saxer, Gerda ;
Shamoo, Yousif .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) :5561-5566
[2]   Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010 [J].
Garza-Gonzalez, Eluira ;
Dowzicky, Michael Joseph .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (01) :13-19
[3]   In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin [J].
Herrera, Melina ;
Di Gregorio, Sabrina ;
Fernandez, Silvina ;
Posse, Graciela ;
Mollerach, Marta ;
Di Conza, Jose .
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2016, 15
[4]   A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline [J].
McAleese, F ;
Petersen, P ;
Ruzin, A ;
Dunman, PM ;
Murphy, E ;
Projan, SJ ;
Bradford, PA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) :1865-1871
[5]   Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014) [J].
Sader, Helio S. ;
Castanheira, Mariana ;
Farrell, David J. ;
Flamm, Robert K. ;
Mendes, Rodrigo E. ;
Jones, Ronald N. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (02) :144-150